Terms: = Ovarian cancer AND CCND3, P30281, 896, ENSG00000112576 AND Diagnosis
17 results:
1. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
2. Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study.
Yoshihara M; Mogi K; Kitami K; Uno K; Iyoshi S; Tano S; Fujimoto H; Miyamoto E; Yoshikawa N; Emoto R; Matsui S; Kajiyama H
Int J Clin Oncol; 2022 Oct; 27(10):1660-1668. PubMed ID: 35906336
[TBL] [Abstract] [Full Text] [Related]
3. Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia.
Sait KH; Alam MZ; Haque A; Sait HK; Sait MK; Anfinan NM
Saudi Med J; 2022 Feb; 43(2):146-155. PubMed ID: 35110339
[TBL] [Abstract] [Full Text] [Related]
4. A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses.
Guo Y; Jiang T; Ouyang L; Li X; He W; Zhang Z; Shen H; You Z; Yang G; Lai H
Gynecol Oncol; 2021 Mar; 160(3):704-712. PubMed ID: 33357959
[TBL] [Abstract] [Full Text] [Related]
5. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial ovarian Tumors.
Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
[TBL] [Abstract] [Full Text] [Related]
6. External validation of Risk of Malignancy Index compared to IOTA Simple Rules.
Mulder EE; Gelderblom ME; Schoot D; Vergeldt TF; Nijssen DL; Piek JM
Acta Radiol; 2021 May; 62(5):673-678. PubMed ID: 32567319
[TBL] [Abstract] [Full Text] [Related]
7. Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.
Gentry-Maharaj A; Burnell M; Dilley J; Ryan A; Karpinskyj C; Gunu R; Mallett S; Deeks J; Campbell S; Jacobs I; Sundar S; Menon U
Am J Obstet Gynecol; 2020 Jan; 222(1):56.e1-56.e17. PubMed ID: 31351062
[TBL] [Abstract] [Full Text] [Related]
8. Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement.
Basha MAA; Refaat R; Ibrahim SA; Madkour NM; Awad AM; Mohamed EM; El Sammak AA; Zaitoun MMA; Dawoud HA; Khamis MEM; Mohamed HAE; El-Maghraby AM; Abdalla AAEM; Assy MM; Nada MG; Obaya AA; Abdelbary EH
Eur Radiol; 2019 Nov; 29(11):5981-5990. PubMed ID: 30993433
[TBL] [Abstract] [Full Text] [Related]
9. Identifying distinct trajectories of change in young breast cancer survivors' sexual functioning.
von Hippel C; Rosenberg SM; Austin SB; Sprunck-Harrild K; Ruddy KJ; Schapira L; Come S; Borges VF; Partridge AH
Psychooncology; 2019 May; 28(5):1033-1040. PubMed ID: 30817075
[TBL] [Abstract] [Full Text] [Related]
10. Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC).
Hopper JL; Dite GS; MacInnis RJ; Liao Y; Zeinomar N; Knight JA; Southey MC; Milne RL; Chung WK; Giles GG; Genkinger JM; McLachlan SA; Friedlander ML; Antoniou AC; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; John EM; Phillips KA; Terry MB
Breast Cancer Res; 2018 Nov; 20(1):132. PubMed ID: 30390716
[TBL] [Abstract] [Full Text] [Related]
11. Significance of blood and salivary IEX-1 expression in diagnosis of epithelial ovarian carcinoma.
Li Y; Tan C; Liu L; Han L
J Obstet Gynaecol Res; 2018 Apr; 44(4):764-771. PubMed ID: 29431239
[TBL] [Abstract] [Full Text] [Related]
12. Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines.
Crawford SM; Evans C
Fam Pract; 2018 Mar; 35(2):199-202. PubMed ID: 29029123
[TBL] [Abstract] [Full Text] [Related]
13. Awareness and Knowledge of ovarian cancer Symptoms and Risk Factors: A Survey of Jordanian Women.
Freij M; Al Qadire M; Khadra M; ALBashtawy M; Tuqan W; Al Faqih M; Innabi A; Batiha AM; Alhalaiqa F; Abd El-Razek A
Clin Nurs Res; 2018 Sep; 27(7):826-840. PubMed ID: 28412839
[TBL] [Abstract] [Full Text] [Related]
14. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
[TBL] [Abstract] [Full Text] [Related]
15. Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions.
Salani R; Davidson B; Fiegl M; Marth C; Müller-Holzner E; Gastl G; Huang HY; Hsiao JC; Lin HS; Wang TL; Lin BL; Shih IeM
Clin Cancer Res; 2007 Oct; 13(19):5805-9. PubMed ID: 17908972
[TBL] [Abstract] [Full Text] [Related]
16. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
[TBL] [Abstract] [Full Text] [Related]
17. Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.
Ben David Y; Chetrit A; Hirsh-Yechezkel G; Friedman E; Beck BD; Beller U; Ben-Baruch G; Fishman A; Levavi H; Lubin F; Menczer J; Piura B; Struewing JP; Modan B;
J Clin Oncol; 2002 Jan; 20(2):463-6. PubMed ID: 11786575
[TBL] [Abstract] [Full Text] [Related]
